National Cancer Institute Monthly Bulletin, 3/24/09, takes a closer look at chemobrain.

Research on treatments for chemobrain is still in its very early stages. BCRF-funded researcher, Dr. Patricia Ganz, MD, is beginning a pilot study of rehabilitation strategies for affected breast cancer survivors. Some evidence suggests that medications that stimulate the central nervous system may moderate adverse cognitive effects.